TITAN PHARMACEUTICAL INC
Symbol: TTNP (NASDAQ)
6.05
▲ (26.37%) 1.263
Company Description:
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
Key Stats
- Today's Open: $4.8
- Today's High: $7.01
- Today's Low: $4.56
- Today's Volume: 3.23M
- Yesterday Close: $4.79
- Yesterday High: $4.79
- Yesterday Low: $4.1525
- Yesterday Volume: 58.23K
- Last Min Volume: 1.48K
- Last Min High: $6.09
- Last Min Low: $6.051
- Last Min VWAP: $6.07328
Company Profile
- Name: TITAN PHARMACEUTICAL INC
- Website: https://www.titanpharm.com
- Listed Date: 1996-01-17
- Location: SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0000910267
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $6.37M
- Round Lot: 100
- Outstanding Shares: 1.33M
- Asset Type: CS
RECENT FILINGS FOR TTNP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-01 | 8-K | View |
| 2025-08-26 | 8-K | View |
| 2025-08-22 | DEFA14A | View |
| 2025-08-14 | DEFA14A | View |
| 2025-08-14 | 10-Q | View |
| 2025-07-22 | DEFA14A | View |
| 2025-07-22 | DEFM14A | View |
| 2025-06-27 | 8-K | View |
| 2025-06-18 | 8-K | View |
| 2025-06-03 | 425 | View |
| 2025-06-03 | 8-K | View |
| 2025-06-02 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-05 | 3 | View |
| 2025-05-02 | DEFA14A | View |
| 2025-05-02 | DEF 14A | View |
| 2025-04-22 | 8-K | View |
| 2025-04-22 | PRE 14A | View |
| 2025-04-16 | 3 | View |
| 2025-04-01 | 8-K | View |
Latest News on TTNP